Congressional Action On Drug Pricing Blueprint Likely To Be Modest

Senate Health, Education, Labor and Pensions Committee Chair Lamar Alexander noted panel's lack of consensus on drug pricing policies advanced by the Trump Administration during June 12 hearing.